Global Cell Separation Technology Market 2023-2030

Description

List of Tables

Title: Global Cell Separation Technology Market Size, Share & Trends Analysis Report by Type (Instruments and Consumables), by Technology (Gradient Centrifugation, Surface Markers Separation, Filtration Based Separation, Immunodensity Cell Separation, and Others), by Application (Oncology, Neuroscience, Stem Cell Research, Microbiology, and Immunology), and by End Users (Research Laboratories & Institutes, Biotechnology & Biopharmaceutical Companies and Hospitals & Diagnostic Laboratories)Forecast Period (2023-2030).

The global cell separation technology market is anticipated to grow at a CAGR of 10.1% during the Forecast Period (2023-2030). Cell separation technology is a key part of many life sciences, from stem cell and oncology research to routine clinical diagnosis. The growing adoption of imaging and spectral technologies with the development across numerous fields is the key factor supporting the growth of the market globally. Researchers can achieve full-spectrum cell sorting, coupled with expanded performance enabled by a new modular optical architecture and system-aware algorithms, to perform high-parameter experiments within a simplified workflow. Hence, the market players are also focusing on introducing cell sorting instrument solutions that further bolster the market growth. For instance, in May 2023, BD (Becton, Dickinson and Company), A medical technology company, launched a new cell sorting instrument featuring two breakthrough technologies that enable researchers to uncover more detailed information about cells. With BD CellView™ Image Technology, researchers can see detailed microscopic images of individual cells and sort at high speeds based on visual characteristics to confirm insights in real time.

Segmental Outlook

The global cell separation technology market is segmented on the type, technology, application and end users. Based on the type, the market is sub-segmented into Instruments (centrifuges, flow cytometers, filtration systems, magnetic-activated cell separator systems) and consumables (reagents, kits, media, and sera, beads, disposables). Based on the technology, the market is sub-segmented into gradient centrifugation, surface markers separation, filtration-based separation, immunodensity cell separation and others (microfluidic cell separation). Based on the application, the market is sub-segmented into oncology, neuroscience, stem cell research, microbiology and immunology. Further, on the basis of end user, the market is sub-segmented into research laboratories & institutes, biotechnology & biopharmaceutical companies and hospitals & diagnostic laboratories. Among the technology, the gradient centrifugation sub-segment is anticipated to hold a considerable share of the market owing to the rise in development of gradient centrifugation that frequently employed techniques in the molecular biology laboratory. Centrifugation is used to collect cells, to precipitate DNA, to purify virus particles, and to distinguish subtle differences in the conformation of molecules.

The Magnetic-Activated Cell Separator Systems Sub-Segment is Anticipated to Hold a Considerable Share of the Global Cell Separation Technology Market

Among the type, the magnetic-activated cell separator systems sub-segment is expected to hold a considerable share of the global cell separation technology market. The segmental growth is attributed to the growing influence of the magnetic cell separation for the isolation of target cell populations from biological suspensions, covering a wide spectrum of applications from diagnosis and therapy in biomedicine to environmental applications or fundamental research in biology. Researchers can now accelerate their discoveries with unprecedented sample processing power and insights. A new gentle, fast, and unbiased method to separate and enrich cells of interest via magnetic levitation. For instance, in April 2022, LevitasBio, Inc. launched the LeviCell™ EOS System, their next-generation solution for cell separation and enrichment, featuring higher throughput and simultaneous targeted selection of viable cells.

Regional Outlook

The global cell separation technology market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to the adoption of advanced technologically solutions. Furthermore, extensive research activities by research universities in the field of cell therapies have created a huge demand for cell separation solutions.

The Asia-Pacific Region is Expected to Grow at a Significant CAGR in the Global Cell Separation Technology Market

Among all regions, the Asia-Pacific regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to growing pharmaceutical and biotechnology industries in emerging economies, such as China and India. Furthermore, continuous stem and gene therapy research initiatives in Japan, China, and South Korea have boosted the demand for cell separation solutions in the region. An increase in the prevalence of chronic disease in the region is the major driving factor for the growth of cell separation technology. According to the National Institute of Health (NIH), in March 2022, About 21.0% of the elderly in India reportedly have at least one chronic disease. 17.0% elderly in rural areas and 29.0% in urban areas suffer from a chronic diseases.

The rising focus on human & cancer research and varied applications of isolated human cells in biopharmaceutical development, clinical trials, and research are among the major factors contributing to market growth. Moreover, favorable reimbursement policies pertaining to personalized medicine in developed countries boost the demand for human cell isolation. The key market players include Sony Biotechnology, Miltenyi Biotec Japan, Himedia Laboratories, Magcrown Biotech, Sinobioway Biomedicine, NanoEntek, Bioneer Corp and others.

Done

Market Players Outlook

The major companies serving the global cell separation technology market include: Corning Inc., Genscript Biotech Corp., Merck KGaA, QIAGEN N.V., Thermo Fisher Scientific Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2022, Applied Cells Inc. and STEMCELL Technologies Inc. collaborated to deliver a new high-performance cell separation solution that combines Applied Cells' MARS® platform with STEMCELL's EasySep™ immunomagnetic cell separation kits. This partnership helps researchers around the world to automate and increase the efficiency of isolating high-quality cells from a wide range of sample types.

The Report Covers:

Market value data analysis of 2022 and forecast to 2030.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global cell separation technology market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market.

Product Code: OMR2027830

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. By Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis
3.2. Genscript Biotech Corp.
- 3.2.1. Overview
- 3.2.2. Financial Analysis
- 3.2.3. SWOT Analysis
- 3.2.4. Recent Developments
3.3. Merck KGaA
- 3.3.1. Oerview
- 3.3.2. Financial Analysis
- 3.3.3. SWOT Analysis
- 3.3.4. Recent Developments
3.4. Thermo Fisher Scientific Inc.
- 3.4.1. Overview
- 3.4.2. Financial Analysis
- 3.4.3. SWOT Analysis
- 3.4.4. Recent Developments
3.5. Key Strategy Analysis

4. Market Segmentation

4.1. Global Cell Separation Technology Market by Type
- 4.1.1. Instruments
  - 4.1.1.1. Centrifuges
  - 4.1.1.2. Flow Cytometers
  - 4.1.1.3. Filtration Systems
  - 4.1.1.4. Magnetic-activated Cell Separator Systems
- 4.1.2. Consumables
  - 4.1.2.1. Reagents, Kits, Media, and Sera
  - 4.1.2.2. Beads
  - 4.1.2.3. Disposables
4.2. Global Cell Separation Technology Market by Technology
- 4.2.1. Gradient Centrifugation
- 4.2.2. Surface Markers Separation
- 4.2.3. Filtration Based Separation
- 4.2.4. Immunodensity Cell Separation
- 4.2.5. Others (Microfluidic Cell Separation)
4.3. Global Cell Separation Technology Market by Application
- 4.3.1. Oncology
- 4.3.2. Neuroscience
- 4.3.3. Stem Cell Research
- 4.3.4. Microbiology
- 4.3.5. Immunology
4.4. Global Cell Separation Technology Market by End Users
- 4.4.1. Research Laboratories & Institutes
- 4.4.2. Biotechnology & Biopharmaceutical Companies
- 4.4.3. Hospitals & Diagnostic Laboratories

5. Regional Analysis

5.1. North America
- 5.1.1. United States
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. Akadeum Life Sciences, Inc.
6.2. Alfa-Laval AB
6.3. Applied Cells Inc.
6.4. Biocompare, Inc.
6.5. BioProcess International™
6.6. Cell Microsystems.
6.7. Corning Inc.
6.8. Cytiva Life Science
6.9. Elvesys group
6.10. ESI Technologies Group
6.11. IBA Lifesciences GmbH
6.12. Miltenyi Biotec
6.13. NanoCellect Biomedical, Inc.
6.14. pluriSelect Life Science
6.15. Proteintech Group
6.16. QIAGEN N.V.
6.17. STEMCELL Technologies Inc.
6.18. Techne Corp.